MannKind will grow in Danbury

By Danielle Brody

No Comment

Danbury-based biotech company MannKind will grow in the city with its diabetes drug Afrezza and in two more treatment areas to be announced Monday.

This content is for Westfair Online members only. Please login to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.


About the author

Danielle Brody
Danielle is the events manager for Westfair Communications. Previously, she was a reporter for the Fairfield and Westchester County Business Journals. She has written for the Journal News, the Scarsdale Inquirer and the Newark Post. Danielle is a graduate of the University of Delaware.

Related Articles